DD vs HOTH · P/E 127, rev $12.39B vs rev $1.24B
Dupont De Nemours Inc (DD) versus Hoth Therapeutics Inc (HOTH) — a side-by-side from cached financials, not a winner call.
Dupont De Nemours Inc (DD) is a specialty chemicals company listed on US.
Hoth Therapeutics Inc (HOTH) is a biotechnology company listed on US.
Latest reported DD revenue for 2024-12-31 was $12.39B. Net income was $738.0M. Revenue was up 2.6% from 2023-12-31 to 2024-12-31. DD currently screens at market cap $19.61B and trailing P/E 127.4.
Latest reported HOTH revenue for 2024-03-31 was $1.24B. Net income was -$2.1M. HOTH currently screens at market cap $15.5M.
DD currently screens at market cap $19.61B and trailing P/E 127.4. HOTH currently screens at market cap $15.5M.
Not investment advice. Open the DD and HOTH stock pages for the full models.
Not investment advice.